Ticker

Analyst Price Targets — IMMP

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
November 15, 2024 12:17 pmJoel BeattyRobert W. Baird$3.50$1.06StreetInsider Immutep Limited (IMMP) PT Raised to $7 at Baird
June 27, 2024 6:42 amJoel BeattyRobert W. Baird$3.00$1.39TheFly Immutep price target lowered to $6 from $7 at Baird
May 17, 2024 7:10 amNaureen QuibriaCapital One Financial$5.00$1.46TheFly Immutep initiated with an Overweight at Capital One

Latest News for IMMP

Immutep Provides Clinical Update in 1st line NSCLC: Positive Mature Overall Survival Data from INSIGHT-003 and Update from TACTI-004

SYDNEY, AUSTRALIA, July 13, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapies, today announced a significant positive update of the investigator-initiated INSIGHT-003 Phase I trial evaluating eftilagimod alfa (efti) in combination with MSD's (Merck & Co. Inc., Rahway, NJ, USA) anti-PD-1 therapy KEYTRUDA®…

GlobeNewsWire • Jul 13, 2026
Immutep Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - IMMP

LOS ANGELES, July 6, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Immutep Limited ("Immutep" or "the Company") (NASDAQ: IMMP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of IMMP during the class period listed are…

PRNewsWire • Jul 6, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for IMMP.

No House trades found for IMMP.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top